Figure 1.
Flowchart of inclusions and exclusions to final cohort used for analyses. Stage IA patients were excluded because Swedish treatment guidelines recommend radiotherapy and no AHCT. Patients not reaching CR after induction chemotherapy were excluded because this group is not eligible for transplantation. allo, allogeneic stem cell transplantation; CR, complete remission; LISA, Longitudinal Integrated Database for Health Insurance and Labor Market Studies; NPR, National Patient Register; SCR, Swedish Cancer Register. *Among these, all patients but two died within 18 months of diagnosis. Median time to death was 8.8 months (range: 6.2 months to 4.6 years). **Among these, 27 patients (18%) had an AHCT after the predefined time period of 18 months postdiagnosis.

Flowchart of inclusions and exclusions to final cohort used for analyses. Stage IA patients were excluded because Swedish treatment guidelines recommend radiotherapy and no AHCT. Patients not reaching CR after induction chemotherapy were excluded because this group is not eligible for transplantation. allo, allogeneic stem cell transplantation; CR, complete remission; LISA, Longitudinal Integrated Database for Health Insurance and Labor Market Studies; NPR, National Patient Register; SCR, Swedish Cancer Register. *Among these, all patients but two died within 18 months of diagnosis. Median time to death was 8.8 months (range: 6.2 months to 4.6 years). **Among these, 27 patients (18%) had an AHCT after the predefined time period of 18 months postdiagnosis.

Close Modal

or Create an Account

Close Modal
Close Modal